医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Malignancy post-op targeted therapy (Z51.807) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Post-op tumor isotope therapy (Z51.806) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Post-op tumor immunotherapy (Z51.805) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Tumor endocrine therapy (Z51.804) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy TCM therapy (Z51.802) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy targeted therapy (Z51.801) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy end-stage targeted therapy (Z51.800x983) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy pre-op targeted therapy (Z51.800x981) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy end-stage immunotherapy (Z51.800x953) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy post-op immunotherapy (Z51.800x952) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy pre-op immunotherapy (Z51.800x951) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy PDT (Z51.800x927) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy laser therapy (Z51.800x925) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy hyperthermia (Z51.800x924) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy perfusion therapy (Z51.800x922) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy cryotherapy (Z51.800x921) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy RFA (Z51.800x097) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy biotherapy (Z51.800x096) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy immunotherapy (Z51.800x095) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
Malignancy endocrine therapy (Z51.800x094) is a disease included in the National Health Commission's 'Disease Classification and Codes, National Clinical Version 2.0' standard; a detailed pathological introduction is being compiled.
|
